Health Catalyst PE Ratio 2018-2024 | HCAT

Current and historical p/e ratio for Health Catalyst (HCAT) from 2018 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Health Catalyst PE ratio as of May 05, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Health Catalyst PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-05 4.07 0.00
2024-12-31 7.07 $-1.15 0.00
2024-09-30 8.14 $-1.35 0.00
2024-06-30 6.39 $-1.50 0.00
2024-03-31 7.53 $-1.85 0.00
2023-12-31 9.26 $-2.10 0.00
2023-09-30 10.12 $-2.23 0.00
2023-06-30 12.50 $-2.68 0.00
2023-03-31 11.67 $-2.72 0.00
2022-12-31 10.63 $-2.66 0.00
2022-09-30 9.70 $-2.94 0.00
2022-06-30 14.49 $-2.92 0.00
2022-03-31 26.13 $-3.10 0.00
2021-12-31 39.62 $-3.21 0.00
2021-09-30 50.01 $-3.28 0.00
2021-06-30 55.51 $-3.14 0.00
2021-03-31 46.77 $-3.05 0.00
2020-12-31 43.53 $-2.87 0.00
2020-09-30 36.60 $-2.25 0.00
2020-06-30 29.17 $-2.97 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.294B $0.307B
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.476B 53.14
Tempus AI (TEM) United States $9.826B 0.00
Hims & Hers Health (HIMS) United States $9.069B 145.79
Inspire Medical Systems (INSP) United States $4.756B 92.38
IRhythm Technologies (IRTC) United States $4.186B 0.00
Privia Health (PRVA) United States $2.829B 212.00
Enovis (ENOV) United States $2.016B 12.47
Schrodinger (SDGR) United States $1.847B 0.00
Clover Health Investments (CLOV) United States $1.706B 0.00
Phreesia (PHR) United States $1.512B 0.00
Omnicell (OMCL) United States $1.460B 31.48
Azenta (AZTA) United States $1.232B 57.36
10x Genomics (TXG) United States $1.031B 0.00
Fulgent Genetics (FLGT) United States $0.634B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.537B 319.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.456B 0.00
TruBridge (TBRG) United States $0.392B 0.00
Claritev (CTEV) United States $0.362B 0.00
Nyxoah SA (NYXH) Belgium $0.208B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.202B 0.00
Pulmonx (LUNG) United States $0.152B 0.00
American Well (AMWL) United States $0.116B 0.00
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
Retrieve Medical Holdings (RMHI) United States $0.085B 0.00
MDxHealth SA (MDXH) Belgium $0.081B 0.00
CareCloud (CCLD) United States $0.080B 3.43
111 (YI) China $0.072B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Precipio (PRPO) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00